Mediolanum International Funds Ltd Lowers Stock Holdings in CVS Health Corporation $CVS

Mediolanum International Funds Ltd lessened its position in CVS Health Corporation (NYSE:CVS) by 82.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 32,054 shares of the pharmacy operator’s stock after selling 152,661 shares during the quarter. Mediolanum International Funds Ltd’s holdings in CVS Health were worth $2,422,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of CVS Health in the second quarter valued at approximately $1,358,698,000. Invesco Ltd. boosted its position in CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after buying an additional 3,118,626 shares during the period. Jennison Associates LLC grew its stake in shares of CVS Health by 111.7% in the second quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock worth $276,895,000 after acquiring an additional 2,117,798 shares in the last quarter. Vanguard Group Inc. increased its position in shares of CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after acquiring an additional 2,063,737 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of CVS Health by 153.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,105,827 shares of the pharmacy operator’s stock valued at $214,240,000 after acquiring an additional 1,878,217 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on CVS shares. Leerink Partners boosted their target price on CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. JPMorgan Chase & Co. raised their target price on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. Barclays boosted their price target on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Finally, TD Cowen raised their price objective on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $94.82.

CVS Health Trading Up 1.8%

Shares of CVS Health stock opened at $76.80 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The company has a fifty day simple moving average of $78.82 and a 200-day simple moving average of $75.43. The stock has a market cap of $97.49 billion, a price-to-earnings ratio of 202.11, a PEG ratio of 0.69 and a beta of 0.50. CVS Health Corporation has a 12-month low of $53.36 and a 12-month high of $85.15.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.